Stocks · Health care · Pharmaceutical Preparations

Nurix Therapeutics, Inc.

NRIX Clue Score49

United States Fiscal year ends November CIK 0001549595 Results filed 13 Oct 2026

Add to watchlist

By person

4 insiders · 49 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Christine Ring

Chief Legal Officer

—

$3.89M (24) scheduled

−$3.89M

4,406

0.0040%

$71.39K

−84.3%

Gwenn Hansen

Chief Scientific Officer

—

$757.80K (12) scheduled

−$757.80K

123,452

0.1130%

$2.00M

+143.6%

Houte Hans van

Chief Financial Officer

—

$665.39K (11) scheduled

−$665.39K

42,745

0.0391%

$692.55K

+26.7%

Julia P Gregory

Director

—

$528.53K (1) scheduled

−$528.53K

10,750

0.0098%

$174.17K

—

Nurix Therapeutics, Inc.

What the insiders did Scheduled selling only

By person